# University Medical Center Mainz: Not applicable (device, behavioral) study started recruiting, 520 planned (Mitral Regurgitation Functional, Heart Failure With Reduced Ejection Fraction (HFrEF))

**Score:** 70/100

| Field | Value |
|---|---|
| Sponsor | University Medical Center Mainz |
| Sponsor type | Academic and hospital |
| Study | Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF |
| NCT ID | NCT07758023 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Mitral Regurgitation Functional; Heart Failure With Reduced Ejection Fraction (HFrEF) |
| Intervention types | device, other |
| Target enrollment | 520 |
| Site countries | Germany |
| Posted | 2026-08-11 |
| Planned start | 2026-10-15 |
| Event | Started recruiting |
| Event date | 2026-10-15 |
| Last update posted | 2026-11-02 |

## Why this score
- Posted in the last two weeks.
- Just started recruiting: sites, recruitment and supply are active.
- 520 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07758023). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.